Therapeutic Strategies against Leishmania and Trypanosoma
Excerpt
Human African trypanosomiasis (also known as sleeping sickness, with Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense as etiological agents), American trypanosomiasis (also known as Chagas disease, with Trypanosoma cruzi as the etiological agent), and leishmaniasis (including cutaneous, mucocutaneous, and visceral forms, with multiple species belonging to the Leishmania genus as etiological agents) are recognized as neglected tropical diseases (NTDs) [...]
Share and Cite
Santos, A.L.S.; Rodrigues, I.A.; d’Avila-Levy, C.M.; Sodré, C.L.; Ritmeijer, K.; Branquinha, M.H. Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens 2023, 12, 1263. https://doi.org/10.3390/pathogens12101263
Santos ALS, Rodrigues IA, d’Avila-Levy CM, Sodré CL, Ritmeijer K, Branquinha MH. Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens. 2023; 12(10):1263. https://doi.org/10.3390/pathogens12101263
Chicago/Turabian StyleSantos, André L. S., Igor A. Rodrigues, Claudia M. d’Avila-Levy, Cátia L. Sodré, Koert Ritmeijer, and Marta H. Branquinha. 2023. "Therapeutic Strategies against Leishmania and Trypanosoma" Pathogens 12, no. 10: 1263. https://doi.org/10.3390/pathogens12101263
APA StyleSantos, A. L. S., Rodrigues, I. A., d’Avila-Levy, C. M., Sodré, C. L., Ritmeijer, K., & Branquinha, M. H. (2023). Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens, 12(10), 1263. https://doi.org/10.3390/pathogens12101263

